Used primarily in research settings for studying immunomodulatory and anticancer mechanisms. It serves as a metabolite reference for lenalidomide in drug metabolism studies. Commonly applied in biochemical assays to evaluate protein degradation, particularly targeting transcription factors involved in cancer progression. Also utilized in the development of targeted protein degradation therapies, including PROTACs (proteolysis-targeting chimeras). Plays a role in enhancing understanding of cereblon E3 ubiquitin ligase modulation. Not intended for therapeutic use.